Angels Dancing on the Tip of a Needle: Interpreting Clinical Trials in Chronic Obstructive Pulmonary Disease

Affiliations

Editorial

Peter Calverley. Am J Respir Crit Care Med. 2020.

. 2020 Nov 1;202(9):1206-1207.

doi: 10.1164/rccm.202007-2863ED.

No abstract available

Comment on

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.
Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S, Lange P, Lettis S, Lipson DA, Lomas DA, Martin N, Wise RA, Singh D, Martinez FJ. Han MK, et al. Am J Respir Crit Care Med. 2020 Nov 1;202(9):1237-1243. doi: 10.1164/rccm.201912-2478OC. Am J Respir Crit Care Med. 2020. PMID: 32584168 Free PMC article. Clinical Trial.

1. Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S, et al. The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study: a randomized, double-blind, multicenter clinical trial. Am J Respir Crit Care Med. 2020;202:1237–1243. - PMC - PubMed
1. Calverley PM, Tetzlaff K, Dusser D, Wise RA, Mueller A, Metzdorf N, et al. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study. Int J Chron Obstruct Pulmon Dis. 2017;12:3391–3405. - PMC - PubMed
1. Hartley B, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Jones CE, et al. Misinterpretation of time-to-first event curves can lead to inappropriate treatment. Eur Respir J. 2019;54:1900634. - PubMed
1. Rossi A, van der Molen T, del Olmo R, Papi A, Wehbe L, Quinn M, et al. INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J. 2014;44:1548–1556. - PubMed
1. Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, et al. WISDOM investigators: withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med. 2014;371:285–294. - PubMed